Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite Laser

Status Enrolling by invitation

Clinical Trial Summary

The purpose of this study is to compare the efficacy of the IPL system 650advance handpiece with the alexandrite laser for the purposes of female facial hair reduction

Clinical Trial Description

This is a randomised (splitface)controlled trial, comparing the use of the Intense Pulsed Light (IPL) system 650 advance handpiece against the Alexandrite Laser for the purposes of female facial hair reduction. Previous studies have shown that the alexandrite laser is superior to IPL in achieving hair reduction. A new handpiece (Lynton, Lumina 650 advance) available for the IPL system is designed to further optimise its use in removing female facial hair (particularly those hair colours previously unresponsive to treatment). This study will compare the alexandrite laser to the IPL system using the new handpiece. This may lead to improvements in the treatment of female patients with male pattern facial hair. Female patients referred to our facial hair reduction service will be recruited to this study. 1/2 their face will be treated with IPL and 1/2 with alexandrite laser. Each participant will receive 6 full treatments at approximately 6 weekly intervals. Participants will be asked to fill in a satisfaction questionnaire and have clinical photographs taken pre treatment and at 1 and 3months post final treatment. All treatments will be carried out in our dedicated laser suite at Glasgow Royal Infirmary. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Hirsutism

Clinical Trial Details

NCT number	NCT01461694
Study type	Interventional
Source	NHS Greater Glasgow and Clyde
Contact
Status	Enrolling by invitation
Phase	Phase 2/Phase 3
Start date	November 2011
Completion date	March 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02103608` - Clinical Evaluation of Silk'n Glide for Face	N/A
Not yet recruiting	`NCT00495443` - Enhanced Safety Aesthetic Laser System	N/A
Not yet recruiting	`NCT06003062` - Suppression of Upper Lip Hair Growth Using Novel Hemp Extract
Active, not recruiting	`NCT00145288` - Prospective Study of Patients With Hirsutism	Phase 2/Phase 3
Completed	`NCT00152048` - Evaluation of Eflornithine on Facial and Forearm Skin	Phase 4
Not yet recruiting	`NCT00441948` - Enhanced Safety Laser Hair Removal System	N/A
Completed	`NCT03673995` - Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS	N/A
Recruiting	`NCT04979377` - Prevalence of Hyperandrogenism in Type 1 Diabetes
Completed	`NCT02494297` - DUS on the Prescribing Indications for CPA/EE in 5 European Countries
Completed	`NCT00960310` - Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions	Phase 1
Completed	`NCT02793557` - Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth	Phase 1/Phase 2
Completed	`NCT01555190` - Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone	N/A
Completed	`NCT01817894` - Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism	Phase 4
Completed	`NCT00143052` - Bone Status and Insulin Resistance in Hirsutism	N/A
Recruiting	`NCT01338519` - Database Study on Patients With PCOS	N/A
Recruiting	`NCT04292587` - Prevalence of Hirsutism in Turkey: Data of The Dermatoendocrinology Study Group
Completed	`NCT00959335` - Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions	Phase 1
Not yet recruiting	`NCT00371930` - Photodynamic Therapy for Permanent Hair Removal	Phase 1/Phase 2